CRS-207
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CRS-207, covering 2009-02-20 to 2025-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer [Phase 2]